Core Insights - Nanox Imaging Ltd has entered into a distribution agreement with Althea France to introduce its CE-marked Nanox.ARC system in the French healthcare sector, marking its fourth distribution agreement in Europe [1][2][3] Company Overview - Nanox is focused on advancing medical imaging technology, aiming to drive the transition to preventive healthcare through affordable solutions that leverage AI and proprietary digital X-ray sources [4][5] Partnership Details - Althea France will manage the market introduction, sales, and service of the Nanox.ARC, which is a multi-source digital tomosynthesis system designed to enhance diagnostic capabilities at a lower cost compared to traditional systems [2][3] - The partnership is expected to leverage Althea's established relationships with hospitals and clinics across France, facilitating the introduction of Nanox's imaging platform [3] Market Strategy - France is identified as a strategic market for Nanox, with the partnership expected to expand access to high-quality, affordable imaging services for patients [3] - The collaboration follows previous agreements in Greece, Romania, and the Czech Republic, indicating a growing presence in the European market [1][2]

Core Viewpoint - Nanox Imaging Ltd has announced a registered direct offering of 3,826,530 ordinary shares, expected to generate approximately $15 million in gross proceeds, aimed at strengthening its balance sheet and supporting growth initiatives [1][3]. Group 1: Offering Details - The offering involves the sale of 3,826,530 ordinary shares to a single institutional investor, with gross proceeds anticipated to be around $15 million before expenses [1]. - The closing of the offering is expected on or about November 25, 2025, pending customary closing conditions [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for working capital and general corporate purposes [2]. Group 3: Company Growth Strategy - The CEO of Nanox stated that the capital raise will enhance the company's balance sheet and accelerate key growth initiatives, including technology advancement, market expansion, and AI infrastructure enhancement [3]. - The company aims to make high-quality medical imaging more accessible globally as it scales deployments and expands capabilities [3]. Group 4: Company Overview - Nanox is focused on transitioning to preventive healthcare through affordable medical imaging technologies, leveraging advanced AI and proprietary digital X-ray sources [6]. - The company's ecosystem includes various components such as Nanox.ARC, Nanox.AI, Nanox.CLOUD, and Nanox.MARKETPLACE, all aimed at improving early detection and treatment in healthcare [7].

Olympe Imagerie to deploy Nanox.ARC at Paris-area Hospital Privé Jacques Cartier MASSY for lung cancer screening applications PETACH TIKVA, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced a collaboration with Olympe Imagerie, a Paris-based group of independent radiologists, to deploy the Nanox.ARC and expand its clinical research evidence generation program in France. The Nanox.ARC system ...

Core Insights - Nanox Imaging Ltd will showcase its Nanox.ARC X multi-source digital tomosynthesis system and AI solutions at the RSNA 2025 Annual Meeting from November 30 to December 4, 2025 [1][2] Product Overview - The Nanox.ARC X system, which received FDA 510(k) clearance in April 2025, enables advanced 3D imaging at lower costs and radiation doses compared to CT scans, applicable for various medical indications [2][4] - Live demonstrations of the Nanox.ARC X will occur every 30 minutes at RSNA booth 3914, along with clinical data presentations supporting digital tomosynthesis [3][6] AI Innovations - Nanox is developing a pulmonary nodule AI solution as part of the Nanox.ARC X, along with two standalone AI innovations for measuring aortic valve calcification and body composition [3][4] - The company aims to leverage AI to enhance routine medical imaging efficiency and improve early detection of chronic conditions [9] Event Details - Presentations at RSNA include a focus on AI and digital tomosynthesis in pulmonary nodule detection and applications in the musculoskeletal system [5][6] - A cocktail event discussing the future of radiology and AI will be hosted by Dr. Lawrence Tanenbaum on December 1, 2025 [6][7] Company Vision - Nanox's vision is to expand its technology's reach beyond hospital settings, providing a comprehensive solution from scan to diagnosis, enhancing health outcomes through early detection and treatment [9]

Core Insights - Nanox Imaging Ltd will report its financial results for Q3 2025 on November 20, 2025, before market open [1] - The conference call to discuss these results will be hosted by CEO Erez Meltzer and CFO Ran Daniel at 8:30 a.m. ET [1] Company Overview - Nanox is focused on transitioning to preventive healthcare through affordable medical imaging technologies utilizing advanced AI and proprietary digital X-ray sources [3] - The company's vision includes expanding its technology's reach beyond hospitals, providing a comprehensive solution from scan to diagnosis, and leveraging AI for improved diagnostic accuracy [4] Product Ecosystem - Nanox.ARC is a multi-source digital tomosynthesis system designed to be cost-effective and user-friendly [4] - Nanox.AI LTD offers an AI-based suite of algorithms that enhance routine CT imaging readings to detect early signs of chronic diseases [4] - Nanox.CLOUD is a cloud-based platform for managing data from Nanox devices, providing tools for in-depth imaging analysis [4] - Nanox.MARKETPLACE is a decentralized marketplace that offers remote access to radiology and cardiology experts, along with a teleradiology services platform [4]

Core Insights - Nanox Imaging Ltd has entered into a distribution agreement with EXRAY, a leading Czech radiography supplier, to introduce its advanced imaging solutions in the Czech Republic [1][4] - The Nanox.ARC, a multi-source digital tomosynthesis system, is designed to provide enhanced diagnostic capabilities at a lower cost compared to traditional systems and has received CE Mark certification for commercialization in the EU [2][4] - EXRAY holds over 50% market penetration in the Czech Republic, with installations in more than half of the country's 200 healthcare facilities, making it a strategic partner for Nanox [3][4] Company Overview - Nanox focuses on transitioning to preventive healthcare through affordable medical imaging technologies, leveraging advanced AI and proprietary digital X-ray sources [5] - The Nanox ecosystem includes various components such as Nanox.ARC, Nanox.AI LTD, Nanox.CLOUD, and Nanox.MARKETPLACE, aimed at improving early detection and treatment of diseases [6] Strategic Importance - The partnership with EXRAY is seen as a significant milestone in Nanox's European expansion, utilizing EXRAY's established relationships with healthcare providers to enhance access to imaging services [4] - EXRAY's CEO emphasized the potential for improved diagnostic capabilities and patient outcomes through this collaboration [4]

Core Viewpoint - Nanox Imaging Ltd is set to report its financial results for Q2 2025 on August 12, 2025, with a conference call scheduled for 8:30 a.m. ET to discuss these results and provide a business update [1]. Company Overview - Nanox is focused on advancing preventive healthcare through affordable medical imaging technologies that utilize advanced AI and proprietary digital X-ray sources [3]. - The company's vision includes expanding its technology's reach beyond hospital settings, offering a comprehensive solution from scanning to diagnosis, and leveraging AI for improved diagnostic accuracy [4]. Product and Service Ecosystem - Nanox.ARC: A multi-source digital tomosynthesis system that is cost-effective and user-friendly [4]. - Nanox.AI LTD: A subsidiary that provides AI-based algorithms to enhance routine CT imaging readings, focusing on early signs of chronic diseases [4]. - Nanox.CLOUD: A cloud-based platform for managing data from Nanox devices, offering tools for detailed imaging analysis [4]. - Nanox.MARKETPLACE: A decentralized marketplace through USARAD Holdings Inc. that provides remote access to radiology and cardiology experts, along with a teleradiology services platform [4].

Core Insights - Nanox Imaging Ltd has announced a clinical and educational collaboration with Keiser University to deploy its advanced imaging system, Nanox.ARC, for training healthcare professionals [1][2] Company Overview - Nanox is focused on transforming healthcare through affordable medical imaging technologies, utilizing advanced AI and proprietary digital X-ray sources [6][7] - The company aims to enhance early detection and treatment of diseases, improving health outcomes globally [7] Product Details - The Nanox.ARC is a 3D digital tomosynthesis imaging system that offers improved sensitivity and specificity compared to traditional X-ray, while also reducing patient radiation exposure and radiologist reading times compared to CT scans [3][9] - The system features a proprietary digital X-ray source powered by cold cathode technology, providing a detailed, layered view of the body [3][9] Collaboration with Keiser University - The Nanox.ARC will be integrated into Keiser University's Radiologic Technology graduate program, allowing students and local medical imaging providers to access the technology for educational purposes [2][5] - This partnership is expected to enhance clinical education and empower future healthcare professionals with innovative diagnostic tools [5] Keiser University Overview - Keiser University is Florida's largest private, non-profit university, serving nearly 20,000 students across 21 campuses and online [4][10] - The university has awarded approximately 100,000 degrees since its establishment in 1977 and is recognized for its contributions to workforce talent in healthcare and nursing [4][10]

Core Insights - Nanox Imaging Ltd will report its financial results for Q1 2025 on May 22, 2025, before market open [1] - The conference call to discuss these results will be hosted by CEO Erez Meltzer and CFO Ran Daniel at 8:30 a.m. ET [1] Company Overview - Nanox is focused on transitioning to preventive healthcare through affordable medical imaging technologies utilizing advanced AI and proprietary digital X-ray sources [3] - The company's vision includes expanding its technology's reach beyond hospital settings, providing a comprehensive solution from scan to diagnosis, and leveraging AI for improved diagnostic accuracy [4] Product Ecosystem - Nanox.ARC is a multi-source digital tomosynthesis system designed to be cost-effective and user-friendly [4] - Nanox.AI LTD offers an AI-based suite of algorithms that enhance routine CT imaging readings to detect early signs of chronic diseases [4] - Nanox.CLOUD is a cloud-based platform for managing data from Nanox devices and providing tools for in-depth imaging analysis [4] - Nanox.MARKETPLACE is a decentralized marketplace providing remote access to radiology and cardiology experts, along with teleradiology services [4]